Drug Discovery · Boston, MA · Founded 2025 · Privately Held (backing)
Operator of a clinical-stage biotechnology company intended to develop novel therapies for pulmonary arterial hypertension through innovative molecular mechanisms. PAhR Therapeutics is based in Boston, MA and was founded in 2025. It was valued at $25 million at its seed round in Jul 2025, the last priced event on record. It has raised $14 million across 1 recorded round; the latest was a $14 million seed round in Jul 2025.
These 3 firms already write checks for companies like PAhR Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.